LWAY vs MGPI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
LWAY exhibits a weak Piotroski F-Score of 3/9, indicating deteriorating fundamental health despite a clean balance sheet. The stock is trading at a severe premium to both its Graham Number ($10.62) and Intrinsic Value ($6.23), suggesting the current price of $24.40 is speculative. While revenue growth is strong at 18%, consistent earnings misses and aggressive insider selling signal a lack of confidence in the current valuation.
MGPI presents a classic 'value trap' profile: fundamentally healthy but operationally declining. While the Piotroski F-Score of 7/9 indicates strong financial health and the balance sheet is robust (Debt/Equity 0.37), the company is facing a severe growth crisis with revenue down 23.5% and EPS down 59.9% YoY. The stock is deeply undervalued on a Price-to-Book (0.57) and Price-to-Sales (0.77) basis, but this is offset by bearish insider activity and a nearly unsustainable dividend payout ratio of 96%.
Compare Another Pair
Related Comparisons
LWAY vs MGPI: Head-to-Head Comparison
This page compares Lifeway Foods, Inc. (LWAY) and MGP Ingredients, Inc. (MGPI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.